AlphaGrep
Institutional investorShanghai · Pre-Seed–Series A
Also known as ALPHAGREP UK LIMITED
Find your way into AlphaGrep
Sign up to see every warm intro you have to AlphaGrep
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AlphaGrep team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
AlphaGrep operates as a quantitative trading and market-making firm rather than a traditional venture investor. It applies advanced mathematical and statistical methods to develop algorithmic trading strategies, which it deploys across all asset classes on more than 30 exchanges globally. The firm is among the leading market makers and top participants by volume on several exchanges and products. Built and led by engineers and mathematicians, its team of over 250 engineers, computer scientists, mathematicians, statisticians and physicists works collaboratively across 10 offices in Asia, Europe and the Americas, with a stated mission of making financial markets more transparent and efficient.
Source: firm website, verified Nov 3, 2026.
Frequently asked questions
- What stage does AlphaGrep invest at?
- AlphaGrep invests at the Pre-Seed, Seed, Series A stages.
- What sectors does AlphaGrep focus on?
- AlphaGrep focuses on AI & Machine Learning, Crypto & Web3, Fintech.
- Where is AlphaGrep located?
- AlphaGrep is headquartered in Shanghai, CN.
Similar investors
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Cherubic Ventures is known for investing before a startup even launches or reaches product-market fit, often as the first institutional investor, while also setting aside half of its latest fund for follow-on support all the way through pre-IPO; it was also one of the first venture firms to operate as a solo general partner and has grown into one of the largest funds run that way. Founded by Matt Cheng, who previously built two companies that each reached over $1 billion in public market value, the firm was designed from the start to invest across both the U.S. and Asia, backing early breakout companies in places like Croatia, Bangladesh, Japan, and Taiwan in addition to the U.S., with its Taipei roots still central to its identity alongside its Silicon Valley presence.
Foundation Capital is an early-stage venture capital firm that commits to founders at the idea stage and maintains long-term relationships with portfolio companies through their growth journey.

.jpeg)


